Tokyo-based Terumo Corp. has agreed to acquire Sequent Medical Inc. for $280 million and up to $100 million in commercial milestones, in a bid to get its hands on the CE-marked Web system for the treatment of cerebral aneurysms. Terumo plans to bring the system to the U.S. market following the completion of its ongoing pivotal trial for FDA approval. Read More
